451
Participants
Start Date
February 12, 2021
Primary Completion Date
April 30, 2021
Study Completion Date
April 30, 2021
Remdesivir
treated with Remdesivir
Erasmus Medical Center, Rotterdam
Hospital Clinico Universitario San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Lariboisiere, Paris
CHU de Nantes, Nantes
Hopital Saint-Louis, Paris
Tel Aviv Sourasky Medical Center, Tel Aviv
Hospital Clínic de Barcelona, Barcelona
Hospital Universitari Vall d'Herbon, Barcelona
Hospital Germans Trias i Pujol, Barcelona
Royal Free Hospital, London
Chelsea & Westminster Hospital, London
Collaborators (1)
Gilead Sciences
INDUSTRY
NEAT ID Foundation
OTHER